| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/16/2009 | CN101530580A Drug for curing ulcerative colitis |
| 09/16/2009 | CN101530577A Chinese medicinal preparation for treating malignant tumor of mouth floor |
| 09/16/2009 | CN101530572A Gastro-enteritis decoction |
| 09/16/2009 | CN101530563A Traditional Chinese medicine composition for treating gastric ulcer and preparation method thereof |
| 09/16/2009 | CN101530562A Pharmaceutical composition for treating female kidney-yin deficiency |
| 09/16/2009 | CN101530553A Pharmaceutical composition with effects of tranquilizing and allaying excitement and preparation method thereof |
| 09/16/2009 | CN101530551A Traditional Chinese medicine composition for nourishing yin and strengthening kidney and preparation method thereof |
| 09/16/2009 | CN101530549A Traditional Chinese medicine composition for invigorating kidney, replenishing essence, benefiting qi and nourishing blood and preparation method thereof |
| 09/16/2009 | CN101530548A Composition with multiple health-care functions and preparation method thereof |
| 09/16/2009 | CN101530531A Panwang vigor pill for improving the functions of human body and preparation method thereof |
| 09/16/2009 | CN101530517A Traditional Chinese compound for curing central obesity and nonalcoholic fatty liver disease and preparation method thereof |
| 09/16/2009 | CN101530516A Chinese medicament for treating appendicitis |
| 09/16/2009 | CN101530513A Medicament for preventing and treating dental diseases and preparation method thereof |
| 09/16/2009 | CN101530507A Medicament for treating cattle/pig constipation, and preparation method thereof |
| 09/16/2009 | CN101530504A Chinese medicinal preparation for treating malignant tumor of tongue |
| 09/16/2009 | CN101530494A Substance for intestinal tract lavation and toxin expelling and preparation method thereof |
| 09/16/2009 | CN101530469A Method for preparing effective component group of water soluble Chinese cassia tree |
| 09/16/2009 | CN101530466A Nano medicament containing oregano oil and vitamins |
| 09/16/2009 | CN101530460A Line products of alcohol-relieving and liver-protecting preparation |
| 09/16/2009 | CN101530440A Oral pharmaceutical preparation of aralia elata total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530437A Method for extracting flavonoid compound from bracken |
| 09/16/2009 | CN101530436A Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 09/16/2009 | CN101530434A Method for preparing silkworm powder, pupa powder or pupa serum powder containing antibacterial peptide and application of same |
| 09/16/2009 | CN101530432A Method for producing degreased concentrated solution of tussah male moth |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN101530424A Preparation of palaeo-oceanographical organism medical stone with muscle-penetrating applying treatment for health preservation, rehabilitation and health care |
| 09/16/2009 | CN101530419A Application of dammarane triterpenes derivative and drug composition containing dammarane triterpenes derivative |
| 09/16/2009 | CN101530416A Composition containing adefovir dipivoxil, and preparation method thereof |
| 09/16/2009 | CN101530399A Silibinin solid self-emusifying tablet and preparation method thereof |
| 09/16/2009 | CN101530392A Omeprazole sodium freeze-dried lipidosome preparation and preparation method thereof |
| 09/16/2009 | CN101530389A Ginsenoside Rg 3 and phospholipid complex and preparing method thereof |
| 09/16/2009 | CN101530253A Sachet with function of health care and use method thereof |
| 09/16/2009 | CN101530200A Formula of donkey-hide glue combined hearth-care series products and preparation method thereof |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540559C Lipoid compound regulator and use thereof |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/16/2009 | CN100540021C Traditional Chinese medicinal composition for treating colonitis, its preparation method and quality control method |
| 09/16/2009 | CN100540001C Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2415065C Oral compositions comprising host-response modulating agent |
| 09/15/2009 | CA2374902C Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation |
| 09/15/2009 | CA2371462C Modified protein matrices |
| 09/15/2009 | CA2362363C Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them |
| 09/15/2009 | CA2309100C Lovastatin compositions derived from red rice fermentation products, fermentation processes and monascus strains therefor |
| 09/15/2009 | CA2270423C Prophylactic/therapeutic agent |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/11/2009 | WO2009111437A2 Monodispersed organic monolayer coated calcium-containing nanoparticles |
| 09/11/2009 | WO2009111417A1 Substituted beta-lactams |
| 09/11/2009 | WO2009110816A1 Pharmaceutical composition based on hepatoprotector and prebiotic, the production and use thereof |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009110335A1 Chewing gum containing eucalyptus extract |
| 09/11/2009 | WO2009110008A1 Anti-ulcer activity of flavone analogs |
| 09/11/2009 | WO2009109525A1 Use of a specific pde4 inhibitor for the treatment and/or prophylaxis of non-alcoholic fatty liver disease |
| 09/11/2009 | WO2009109356A1 Cytostatic compositions |
| 09/11/2009 | WO2009033729A3 Therapeutic uses of gastrin- 1 and g- pen-grgdspca |
| 09/11/2009 | WO2009030065A8 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 09/11/2009 | WO2009019571A3 Method of dissolving essential oils in water |
| 09/11/2009 | WO2008096171A3 Natural laxative composition comprising prunes, raisins, apricots, dates, figs, olive oil, senna and honey |
| 09/11/2009 | CA2753844A1 Compositions and methods for mucositis and oncology therapies |
| 09/11/2009 | CA2718549A1 In vivo temporal control of activatable matrix-degrading enzymes |
| 09/10/2009 | US20090227768 Anti-Allergic Complex Molecules |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227597 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 09/10/2009 | US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227512 Methods and compositions for treating and preventing distal bowel lesions |
| 09/10/2009 | US20090227501 Agents for preventing and/or treating upper digestive tract disorders |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090226936 Tetrahydrofolate Synthetase Gene |
| 09/10/2009 | US20090226549 Herbal extracts and flavor systems for oral products and methods of making the same |
| 09/10/2009 | US20090226545 Anti-Glycation Methods and Compositions |
| 09/10/2009 | US20090226513 Na/K-ATpase Ligand |
| 09/10/2009 | US20090226511 Novel pharmaceutical formulation in the form of cellulose capsules suitable for benzimidazole derivatives |
| 09/10/2009 | US20090226469 Shiga Toxoid Chimeric Proteins |
| 09/10/2009 | US20090226460 Compositions and methods for the treatment of disease |
| 09/10/2009 | US20090226437 Humanized anti-beta7 antagonists and uses therefor |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/09/2009 | EP2098598A1 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis c |
| 09/09/2009 | EP2098515A1 Substituted carbinol compound |
| 09/09/2009 | EP2098250A1 Orally disintegrating solid preparation |
| 09/09/2009 | EP2098248A1 Combination of anticholinergics, glucocorticoids and beta2-agonists for the treatment of inflammatory diseases |
| 09/09/2009 | EP2098245A1 Use of cholinesterase for manufacturing an anti-tachykinins medicament |
| 09/09/2009 | EP2098241A1 Method for preventative treatment of health problems in calving cows |
| 09/09/2009 | EP2098238A1 Helicobacter pylori growth inhibitor containing -n-acetylglucosaminyl-binding monosaccharide derivative |
| 09/09/2009 | EP2098236A1 Cytostatic compositions |
| 09/09/2009 | EP2098227A1 Noncarious material and anticarious agent containing rare sugar |
| 09/09/2009 | EP2097452A1 Delivery of binding molecules to induce immunomodulation |
| 09/09/2009 | EP2097378A1 Novel seh inhibitors and their use |
| 09/09/2009 | EP2097137A1 Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases. |
| 09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 09/09/2009 | EP2097079A2 Modulation of prostaglandin/cyclooxygenase metabolic pathways |